Enterprise Value

-23.35M

Cash

103.1M

Avg Qtr Burn

-11.31M

Short % of Float

0.64%

Insider Ownership

16.65%

Institutional Own.

68.01%

Qtr Updated

03/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date